Early research (Phase 1)Study completedNCT02072018What this trial is testingPeyronie's Disease Treatment ProtocolWho this might be right forPeyronie's Disease Hybrid Medical 22
Early research (Phase 1)Study completedNCT06787586What this trial is testingSafety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic PruritusWho this might be right forNormal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more Attovia Therapeutics Inc 108
Testing effectiveness (Phase 2)Study completedNCT02656043What this trial is testingA Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical GelWho this might be right forAcne Vulgaris Xenon Pharmaceuticals Inc. 213
Early research (Phase 1)Study completedNCT04535752What this trial is testingA Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)Who this might be right forSafety and Tolerability in Healthy Volunteers Annexon, Inc. 48
Early research (Phase 1)Study completedNCT04808414What this trial is testingSAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy VolunteersWho this might be right forBacterial Infections Qpex Biopharma, Inc. 104
Testing effectiveness (Phase 2)Ended earlyNCT04375514What this trial is testingStudy of ARO-ENaC in Healthy Volunteers and in Patients With Cystic FibrosisWho this might be right forCystic Fibrosis, Pulmonary Arrowhead Pharmaceuticals 43
Early research (Phase 1)Study completedNCT05917938What this trial is testingA Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionWho this might be right forHepatic ImpairmentHealthy Volunteers Novo Nordisk A/S 33
Early research (Phase 1)Study completedNCT04296799What this trial is testingSMP-100 in Normal Healthy VolunteersWho this might be right forHealthy Volunteers Chengdu SciMount Pharmatech Co., Ltd. 53
Early research (Phase 1)Study completedNCT00787007What this trial is testingSafety and Pharmacokinetic Study of S-Equol in Healthy VolunteersWho this might be right forHealthy Ausio Pharmaceuticals, LLC 60
Early research (Phase 1)UnknownNCT02778386What this trial is testingEvaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal PatientsWho this might be right forToxicity N&N Pharmaceuticals Inc. 28
Early research (Phase 1)Study completedNCT06342713What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological DiseasesWho this might be right forHealthy ParticipantsHealthy SubjectsHealthy Volunteers+4 more BeiGene 203
Early research (Phase 1)Study completedNCT03063489What this trial is testingEvaluation of the Safety, Systemic Pharmacokinetics, and TolerabilityWho this might be right forEye Pain Bausch Health Americas, Inc. 15
Early research (Phase 1)Study completedNCT05117294What this trial is testingASP0367 in People With Kidneys That do Not Work Well and in Healthy PeopleWho this might be right forRenal ImpairmentHealthy Volunteers Astellas Pharma Global Development, Inc. 13
Early research (Phase 1)Study completedNCT06858696What this trial is testingInvestigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic FunctionWho this might be right forHepatic Insufficiency X4 Pharmaceuticals 39
Testing effectiveness (Phase 2)Looking for participantsNCT07317544What this trial is testingStudy of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic AlopeciaWho this might be right forAndrogenetic Alopecia (AGA)Healthy Volunteers - Male and Female Absci Pty Ltd. 227
Early research (Phase 1)Study completedNCT06435507What this trial is testingPhase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy VolunteersWho this might be right forHerpes Simplex Virus Innovative Molecules GmbH 18
Early research (Phase 1)Ended earlyNCT02936492What this trial is testingBAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics StudyWho this might be right forPsoriasis Bayer 32
Early research (Phase 1)Study completedNCT02213315What this trial is testingA Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese SubjectsWho this might be right forHealthy Volunteers MedImmune LLC 39
Early research (Phase 1)Study completedNCT05214677What this trial is testingClinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809Who this might be right forOsteoarthritisRheumatoid ArthritisBack Pain+1 more Daewon Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Study completedNCT05134727What this trial is testingAssess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsWho this might be right forIdiopathic Pulmonary Fibrosis AstraZeneca 63